Insider Cluster (2 insiders) ·Filed Jun 16, 2026

GILD

GILEAD SCIENCES, INC.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago
Insider cluster: 2 insiders, $559K total
Actionable Insight • Neutral

This insider cluster is too small to warrant a trading signal. Monitor for any material corporate events (earnings, pipeline updates, M&A) that could explain the sales, but the dollar amount is routine for a large-cap biopharma. No immediate action needed.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
GILD ▲ +14.56% at T+60d
NEUTRAL call ✓ call won +14.56% · α vs SPY +11.41% · entry $125.45 → $143.72
Entry anchored
Jun 16, 04:12 PM ET
via exchange tick
T+1d
-1.35%
call -1.35% · α -2.13%
$123.76
settled 4mo ago
T+5d
-0.23%
call -0.23% · α +0.81%
$125.16
settled 3mo ago
T+20d
+8.65%
call +8.65% · α +7.33%
$136.30
settled 3mo ago
T+60d
+14.56%
call +14.56% · α +11.41%
$143.72
settled 21d ago

Price Chart

Loading chart...

Executive Summary

Two GILD executives (CFO and Chief Communications & Corporate Affairs Officer) sold a combined $559K in open-market shares on June 15, 2026. The dollar amount is negligible relative to GILD's $154B market cap (0.00036%), and the sales are likely routine portfolio adjustments rather than a bearish signal. Non-cash derivative exercises and tax-withholding transactions by the CEO and other officers on June 10 are standard compensation events with no economic impact.

Key Financial Metrics

Direction
selling
Total Value
$559.0K
Insiders
2

Key Facts

  • CFO Andrew Dickinson sold 3,000 shares at $125.40 for $376K on June 15.
  • Chief Comm & Corp Aff Officer Johanna Mercier sold 1,480 shares at $123.42 for $183K on June 15.
  • Total open-market sales: $559K, representing 0.00036% of market cap.
  • CEO Daniel O'Day and other executives exercised options and surrendered shares for tax withholding on June 10 — non-cash events.

Financial Impact

Negligible — $559K in insider sales against $154B market cap.

insider ownership

Risk Factors

  • Insider sales could precede negative news, but the tiny size makes this unlikely.
  • Historical GILD reports have underperformed at T+20 (avg -2.05%), but this filing is too trivial to be informative.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
82% bullish (39 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-GILD-1781647358670
16 reports for GILD
Performance horizon
83% Hit rate 5 of 6 directional calls best @ T+60▲ +16.72%Jul 6, 2026
Filters
Rows
Reports for GILD — sortable, filterable
TypeNow
Sep 2, 2026
4w ago
Insider Cluster
NEUTRAL ★ 2/10
$149.61 $149.05▼ −0.37%▼ −0.04%$144.74 (−3.26%)
Aug 27, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$145.68 $152.21▲ +4.48%▲ +4.22%$144.74 (−0.65%)
Aug 21, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$146.74 $152.67▲ +4.04%▲ +2.73%$144.74 (−1.36%)
Aug 18, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$147.60 $150.89▲ +2.23%▲ +4.18%$144.74 (−1.94%)
Aug 18, 2026
6w ago
Court Ruling
BULLISH ★ 7/10
$143.44 $147.68▲ +2.96%▲ +4.27%$144.74 (+0.91%)
Aug 13, 2026
7w ago
Court Ruling
BULLISH ★ 6/10
$138.14 $143.72▲ +4.04%▲ +5.79%$144.74 (+4.78%)
Aug 6, 2026
8w ago
S-3ASR
NEUTRAL ★ 2/10
$133.21 $151.00▲ +13.35%▲ +13.75%$144.74 (+8.66%)
Jul 21, 2026
10w ago
ANALYST-DOWNGRADE
BEARISH ★ 4/10
$130.28 $143.44▼ −10.10%▼ −7.54%$144.74 (−11.10%)
Jul 16, 2026
11w ago
Insider Cluster
NEUTRAL ★ 2/10
$134.28 $138.33▲ +3.02%▼ −1.43%$144.74 (+7.79%)
Jul 6, 2026
12w ago
ANALYST-UPGRADE
BULLISH ★ 3/10
$129.61 $130.21▲ +0.46%▲ +1.03%$144.74 (+11.67%)
Showing 10 of 16

US Market Status

Market Closed — Opens Mon (65h 9m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jun 16, 2026